ArticleHealth science reports2024
Challenges Associated With Re-Emergence of Lassa Fever in Nigeria: An Exploratory Study of Epidemiology, Phylogenomics, and Recommendations Toward Its Eradication.
Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Emerging Mammarenaviruses in Wildlife: Expanding Host Range and Implications.Animals : an open access journal from MDPI · 2026Review
- A Review of the Epidemiology of Lassa Fever in Nigeria.Microorganisms · 2025Review
- The resurgence of Lassa fever in Nigeria: economic impact, challenges, and strategic public health interventions.Frontiers in public health · 2025Article
- Avian Influenza Screening in Captive Wild Birds and Biosecurity Appraisal of Zoological Gardens in Southwestern Nigeria.Veterinary medicine international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lassa fever (LF) is a viral hemorrhagic illness endemic in Nigeria and other West African countries. In recent years, the number of reported cases of LF in Nigeria has increased. In this study, we discussed the epidemiology of LF, the phylogenomics of the LF virus, issues associated with the increased cases of LF, and recommendations for tackling the future occurrence of LF in Nigeria. Methods: Epidemiology data on LF were obtained from the Nigeria Centre for Disease Control database and analyzed using Microsoft Excel software. About 59 partial and complete sequences consisting of both small and large segments of the LF virus were retrieved from the National Center for Biotechnology Information from 1969 to 2013 to study the evolutionary relationship of the LF virus in Nigeria. Results: Nigeria has been shown to have the highest prevalence of Lassa fever among African countries, with seasonal occurrence in both wet and dry seasons. Furthermore, the phylogenetic analysis of the LF virus showed a great relationship with several outbreaks of LF in Nigeria and other African countries. Conclusion: To combat the increasing cases of LF in Nigeria, there is a need to increase the molecular diagnosis capacity in Nigeria, improve public health awareness about the disease in rural and urban settlements, integrate a surveillance system through the One Health lens, and support LF vaccine research in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.